Extending Principles Learned in Model Systems to Clinical Trials Design
August 1st 1998Clinical results with irinotecan (CPT-11 [Camptosar]) and other camptothecin derivatives in various cancers, although encouraging, have fallen short of the expectations predicted by preclinical models. One proposed